Skip to main content

Quantitative analysis of circulating plasma DNA as a tumor marker in thoracic malignancies.

Herrera LJ, Raja S, Gooding WE, El-Hefnawy T, Kelly L, Luketich JD, Godfrey TE

Publication: Clin Chem (2005) • Vol 51 • Page 113-8PMID: 15539466View on PubMed

Purpose

The purpose of this paper was to determine if centrifugation protocol and a diagnosis of esophageal cancer impact cell-free plasma DNA levels.

Conclusion

Although a significant effect of diagnosis on plasma DNA levels was observed in retrospectively collected specimens centrifuged once for 5 min, a similar difference was not observed in prospectively collected specimens centrifuged twice for 10 min.

Studies (1)

Purpose

The purpose of this study was to determine if centrifugation protocol and a diagnosis of esophageal cancer impact cell-free plasma DNA levels. Prospectively collected blood from 38 patients with esophageal cancer, 25 patients with lung cancer, 28 patients with gastroesophageal reflux disease and 11 healthy controls were compared with retrospectively collected blood from 20 patients with esophageal cancer and 23 patients with gastroesophageal reflux disease (GERD). Both prospective and retrospective specimens were collected into 10 mL EDTA tubes, centrifuged at 1600 x g within 1 h and stored as frozen plasma at -80ºC. However, retrospectively collected specimens were centrifuged once for 5 min, while prospectively collected specimens were centrifuged twice for 10 min. DNA was extracted from all specimens using the QIAamp Blood DNA Mini Kit. Cell-free DNA was quantified by real-time PCR amplification of beta-actin.

Summary of Findings

While significantly higher levels of plasma DNA were found in retrospectively collected esophageal cancer specimens than in control patients with GERD (p=0.0287), there was no effect of diagnosis on plasma DNA levels in prospectively collected specimens. ANOVA analysis identified a significant interaction between collection (prospective versus retrospective) and diagnosis (GERD versus esophageal cancer) (p=0.0400), which the authors attribute to differences in specimen centrifugation protocol (once for 5 min versus twice for 10 min).

  • Biospecimens

    FluidBlood
    FluidPlasma
  • Preservation Types

    Frozen
  • Diagnoses

    NeoplasticCarcinoma
    Normal
    Other diagnoses
  • Platforms

    DNAReal-time qPCR
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    PreaquisitionDiagnosis/ patient condition
    Esophageal cancer
    GERD
    Healthy
    Lung cancer
    Biospecimen Aliquots and ComponentsCentrifugation
    Different number of centrifugation steps compared
    Multiple durations compared